Publication | Closed Access

Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis

NanoparticlesTissue EngineeringNanomedicineLiver FibrosisAtorvastatin-loaded Chitosan NanoparticlesHepatologyPromising ApproachEngineeringMedicineLiver PhysiologyTherapeutic NanomaterialsPharmaceutical NanotechnologyNano-drug DeliveryBiomedical EngineeringMatrix BiologyPharmacologyExtracellular Matrix